{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:24:10Z","timestamp":1789759450679,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clindermatol.2022.02.009","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T11:31:29Z","timestamp":1645097489000},"page":"363-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The genetics of pediatric cutaneous autoimmunity: The sister diseases vitiligo and alopecia areata"],"prefix":"10.1016","volume":"40","author":[{"given":"Nanette","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2022.02.009_bib0001","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2013.08.041","article-title":"Genetic variants regulating immune cell levels in health and disease","volume":"155","author":"Orr\u00f9","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0002","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0003","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2016-1821","article-title":"A longitudinal follow-up of autoimmune polyendocrine syndrome type 1","volume":"101","author":"Bruserud","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0004","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1713301","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.immuni.2015.04.021","article-title":"Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases","volume":"42","author":"Oftedal","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0006","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2004.02561.x","article-title":"Autoimmune polyglandular syndrome Type 2: the tip of an iceberg?","volume":"137","author":"Betterle","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0007","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00439-002-0687-5","article-title":"Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA","volume":"110","author":"Arcos-Burgos","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0008","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.0022-202X.2005.23822.x","article-title":"Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo","volume":"125","author":"Alkhateeb","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0011","unstructured":"Online Mendelian Inheritance in Man. Autoimmunity disease, susceptibility to, 3; AIS3. Available at: http:\/\/omim.org\/entry\/608392?search=ais3&highlight=ais3. Accessed March 31, 2019."},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0012","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1086\/430279","article-title":"A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families","volume":"76","author":"Chen","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0013","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0014","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ng.602","article-title":"Common variants in FOXP1 are associated with generalized vitiligo","volume":"42","author":"Jin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fgene.2015.00249","article-title":"FOXP3 is a promising and potential candidate gene in generalised vitiligo susceptibility","volume":"6","author":"Jahan","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0016","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/381134","article-title":"Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis","volume":"74","author":"Spritz","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0017","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/jid.2012.37","article-title":"Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation","volume":"132","author":"Jin","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0018","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2017.01.014","article-title":"Large intragenic deletion in DSTYK underlies autosomal-recessive complicated spastic paraparesis, SPG23","volume":"100","author":"Lee","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0019","first-page":"57","article-title":"The role of VIT1\/FBXO11 in the regulation of apoptosis and tyrosinase export from endoplasmic reticulum in cultured melanocytes","volume":"26","author":"Guan","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2350-11-56","article-title":"Promoter polymorphism -119C\/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1","volume":"11","author":"Philips","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2340\/00015555-0999","article-title":"The PRO2268 gene as a novel susceptibility locus for vitiligo","volume":"91","author":"Douroudis","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0022","unstructured":"Online Mendelian Inheritance in Man. T-cell receptor alpha chain constant region; TRAC. Available at: http:\/\/omim.org\/entry\/186880?search=trac%20gene&highlight=%22trac%20gene%22%20gene%20trac. Accessed March 31, 2019."},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0023","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.185","article-title":"A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse","volume":"40","author":"Rosengren Pielberg","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0024","first-page":"2804","article-title":"CAPN3, DCT, MLANA and TYRP1 are overexpressed in skin of vitiligo vulgaris Mexican patients","volume":"15","author":"Salinas-Santander","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/jmg.31.1.72","article-title":"De novo deletion (2) (p11.2p13): clinical, cytogenetic, and immunological data","volume":"31","author":"Los","year":"1994","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0026","doi-asserted-by":"crossref","first-page":"E1335","DOI":"10.1210\/jc.2015-2126","article-title":"FoxD3 variant is associated with vitiligo and elevated thyroid auto-antibodies","volume":"100","author":"Schunter","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0027","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.braindev.2006.11.004","article-title":"Kabuki syndrome with trichrome vitiligo, ectodermal defect and hypogammaglobulinemia A and G","volume":"29","author":"Zannolli","year":"2007","journal-title":"Brain Dev"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0028","first-page":"783","article-title":"Common variable immunodeficiency in vitiligo","volume":"145","author":"Arunachalam","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0029","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng.748","article-title":"Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature","volume":"43","author":"Briggs","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/path.1538","article-title":"Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF\/KIT protein interactions and the downstream effector, MITF-M","volume":"202","author":"Kitamura","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0031","unstructured":"Online Mendelian Inheritance in Man. G protein-coupled receptor 143; GPR143. Available at: https:\/\/omim.org\/entry\/300808. Accessed July 1, 2019."},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0032","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.1074\/jbc.M102391200","article-title":"The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I","volume":"276","author":"Hedstrand","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0033","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1086\/511442","article-title":"Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata","volume":"80","author":"Martinez-Mir","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0034","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archderm.1987.01660260104024","article-title":"Familial focal alopecia. A new disorder of hair growth clinically resembling pseudopelade","volume":"123","author":"Headington","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0035","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1086\/301717","article-title":"A gene for universal congenital alopecia maps to chromosome 8p21-22","volume":"62","author":"N\u00f6then","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0036","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood-2014-06-578542","article-title":"Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0037","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jmedgenet-2014-102856","article-title":"Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes","volume":"52","author":"Hufnagel","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0038","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ajmg.a.32692","article-title":"Encephalocraniocutaneous lipomatosis (ECCL) in a patient with history of familial multiple lipomatosis (FML)","volume":"149A","author":"Prontera","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0039","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jdcr.2018.03.004","article-title":"A novel AIRE gene mutation in a patient with autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy revealed by alopecia areata","volume":"4","author":"Arousse","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1399-0004.2009.01278.x","article-title":"Novel and recurrent mutations in the AIRE gene of autoimmune polyendocrinopathy syndrome type 1 (APS1) patients","volume":"76","author":"Faiyaz-Ul-Haque","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0041","first-page":"639","article-title":"Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region","volume":"106","author":"Tazi-Ahnini","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0042","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0043","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00191802","article-title":"Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata","volume":"96","author":"Galbraith","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0044","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI41931","article-title":"Mutation in the TCR\u03b1 subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of TCR\u03b1\u03b2+ T cells","volume":"121","author":"Morgan","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0046","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/jidsymp.2013.3","article-title":"Genes and immune response in alopecia areata: review of the alopecia areata research summit first day proceedings","volume":"16","author":"Norris","year":"2013","journal-title":"Investig Dermatol Symp Proc"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0047","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.det.2016.11.013","article-title":"Genetics of vitiligo","volume":"35","author":"Spritz","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0048","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0049","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.4238\/2015.May.25.6","article-title":"Associations between TNF-\u03b1 polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: a meta-analysis","volume":"14","author":"Lee","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0050","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1073\/pnas.1523482113","article-title":"MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo","volume":"113","author":"Cavalli","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0051","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.12659\/MSM.910515","article-title":"Identification of the risk HLA-A alleles and autoantigen in Han Chinese vitiligo patients and the association of CD8+T cell reactivity with disease characteristics","volume":"24","author":"Yi","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0052","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/ijd.13194","article-title":"Association of class I and II HLA alleles and haplotypes with susceptibility to vitiligo: a study of patients with vitiligo from southeast Brazil","volume":"55","author":"Ramire","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0053","first-page":"359","article-title":"Study of human leukocyte antigen-cw in Egyptian patients with vitiligo","volume":"14","author":"Hassab El Naby","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0054","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jdermsci.2005.07.008","article-title":"Association of HLA class I alleles with aloplecia areata in Chinese Hans","volume":"41","author":"Xiao","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00251-013-0703-z","article-title":"Association analysis of the HLA-C gene in Japanese alopecia areata","volume":"65","author":"Haida","year":"2013","journal-title":"Immunogenetics"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0056","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2133.2011.10466.x","article-title":"Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population","volume":"165","author":"Megiorni","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0057","first-page":"363","article-title":"Investigation of the HLA-DRB1 locus in alopecia areata","volume":"16","author":"Entz","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0058","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1468-3083.2012.04501.x","article-title":"Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo","volume":"27","author":"Kroon","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0059","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2133.2011.10597.x","article-title":"Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata","volume":"165","author":"Kemp","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121949","article-title":"High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata","volume":"3","author":"de Jong","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0061","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.1900027","article-title":"The role of memory CD8+ T cells in vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0062","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.12.003","article-title":"CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase","volume":"69","author":"Ito","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0063","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4049\/jimmunol.1501798","article-title":"CXCR3 blockade inhibits t cell migration into the skin and prevents development of alopecia areata","volume":"197","author":"Dai","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0064","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jid.2016.10.048","article-title":"CXCR3 depleting antibodies prevent and reverse vitiligo in mice","volume":"137","author":"Richmond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/ijt.ijt_80_18","article-title":"Serum interleukin-15 is a marker of alopecia areata severity","volume":"11","author":"Ebrahim","year":"2019","journal-title":"Int J Trichology"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0066","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1126\/scitranslmed.aam7710","article-title":"Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo","volume":"10","author":"Richmond","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0067","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5021\/ad.2017.29.2.156","article-title":"The contributory roles of Th17 lymphocyte and cytotoxic T lymphocyte at the hair bulge region as well as the hair bulb area in the chronic alopecia areata patients","volume":"29","author":"Hong","year":"2017","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0068","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0069","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/08820139.2013.857351","article-title":"Association of HSPA1B SNP rs6457452 with alopecia areata in the Korean population","volume":"43","author":"Seok","year":"2014","journal-title":"Immunol Invest"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0070","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2008.45","article-title":"HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo","volume":"128","author":"Denman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0071","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0072","first-page":"666","article-title":"Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata","volume":"47","author":"Moravvej","year":"2018","journal-title":"Immunol Invest"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0073","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00403-013-1354-5","article-title":"Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata","volume":"305","author":"Kalkan","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2022.02.009_bib0075","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X22000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:20:01Z","timestamp":1760034001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X22000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0738081X22000244"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.02.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetics of pediatric cutaneous autoimmunity: The sister diseases vitiligo and alopecia areata","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2022.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}